The combination of FOLFOXIRI and molecular-targeted therapies, including bevacizumab, is a first-line treatment for mCRC (metastatic colorectal cancer) patients, i.e., more effective than chemotherapy alone.
โ
๐๐๐ญ ๐
๐ฎ๐ฅ๐ฅ ๐๐๐ฉ๐จ๐ซ๐ญ: - https://www.marknteladvisors.c....om/research-library/
#colorectal_cancer_market #crc #colorectalcancer #antimetabolites #immunotherapy #tumor #marketresearch #healthcare #marknteladvisors



1 (877) 773-1002